New Cambridge, Office for Alfa Aesar
News Jun 02, 2015
The company opened a new commercial office in Cambridge UK on 1st June 2015.
This is a new and exciting chapter in Alfa Aesar’s UK history, with the opening of this office on the Cambourne Business Park, just west of Cambridge.
Aaron Venables, Head of Global Marketing commented “An important aspect is that it will serve as a platform to further increase our customer focus; with the majority of our top customers in the UK being less than an hour away. Furthermore, Cambridge is one of Europe's leading centres of science and culture and has become the focus for companies turning technology, research and development into tomorrow's commercial successes”.
He added “It will also bring together the sales and marketing personnel currently working remotely in the area into one location. Enabling us to leverage all of the skill sets to drive productivity and efficiency, while building a culture of being results focused and a team spirit that allows us to have fun, produce great quality work and develop together”.
The new office has the potential to become a global Centre of excellence for the commercial functions. The core office opening hours are 8.30am - 6.00pm, Monday to Friday.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
Highly Potent Active Pharmaceutical Ingredients (HPAPI)
May 21 - May 22, 2018